Targeting T cell malignancies using CAR-based immunotherapy: challenges and potential solutions

Overview of attention for article published in Journal of Hematology & Oncology, December 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news: 1 news outlet
twitter: 3 X users

patent: 4 patents

Citations

dimensions_citation: 81 Dimensions

Readers on

mendeley: 114 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 4 patents that reference this research output.

CHIMERIC ANTIGEN RECEPTOR (CAR) TO A TCR BETA-CHAIN VARIABLE REGION

Application WO-2024042318-A1

World Intellectual Property Organisation (WIPO)

CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS

Application WO-2022223975-A1

World Intellectual Property Organisation (WIPO)

CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS

Application WO-2022223976-A1

World Intellectual Property Organisation (WIPO)

FULLY HUMAN ANTIBODY TARGETING CD5, AND FULLY HUMAN CHIMERIC ANTIGEN RECEPTOR (CAR) AND…

Application WO-2022089644-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.